Literature DB >> 16236562

Determination of schizandrin in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.

Meijuan Xu1, Guangji Wang, Haitang Xie, Rui Wang, Wei Wang, Xiaoyu Li, Hao Li, Danni Zhu, Lei Yue.   

Abstract

A sensitive liquid chromatography-mass spectrometric (LC/MS) method for the quantification of schizandrin in rat plasma was developed and validated after solid-phase extraction (SPE). Chromatographic separation was achieved on a reversed-phase Shimadzu C(18) column with the mobile phase of acetonitrile-sodium acetate (10 micromol/L) and step gradient elution resulted in a total run time of about 11.7 min. The analytes were detected using an electrospray positive ionization mass spectrometry in the selected ion monitoring (SIM) mode. A good linear relationship was obtained in the concentration range studied (0.005-2.000 microg/mL) (r=0.9999). Lower limit of quantification (LLOQ) was 5 ng/mL and the lower limit of detection (LLOD) was 2 ng/mL using 100 microL plasma sample. Average recoveries ranged from 75.85 to 88.51% in plasma at the concentrations of 0.005, 0.100 and 1.000 microg/mL. Intra- and inter-day relative standard deviations were 5.95-12.93% and 3.87-14.53%, respectively. This method was successfully applied for the pharmacokinetic studies in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236562     DOI: 10.1016/j.jchromb.2005.09.029

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Gender difference regarding schizandrin pharmacokinetics in rats.

Authors:  Mei-Juan Xu; Guang-Ji Wang; Hai-Tang Xie; Hao Li; Qing Huang; Rui Wang; Yuan-Wei Jia; Tian Lv
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Apr-Jun       Impact factor: 2.441

2.  Effects of cinnamon granules on pharmacokinetics of berberine in Rhizoma Coptidis granules in healthy male volunteers.

Authors:  Zhaoyi Huang; Fu'er Lu; Hui Dong; Lijun Xu; Guang Chen; Xin Zou; Hongwei Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

3.  From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors.

Authors:  Lijia Xu; Nicole Grandi; Claudia Del Vecchio; Daniela Mandas; Angela Corona; Dario Piano; Francesca Esposito; Cristina Parolin; Enzo Tramontano
Journal:  J Microbiol       Date:  2015-03-04       Impact factor: 3.422

4.  Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties.

Authors:  Zhong-Jiao Jiang; Chun-Yang Wang; Xun Xie; Jing-Fang Yang; Jun-Ni Huang; Zhi-Ping Cao; Peng Xiao; Chu-Hua Li
Journal:  Br J Pharmacol       Date:  2015-03-26       Impact factor: 8.739

5.  Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats.

Authors:  Ruimiao Chang; Yong Li; Xingxin Yang; Yuan Yue; Lili Dou; Yanwei Wang; Weifang Zhang; Xiaoni Li
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice.

Authors:  Di Hu; Yunfeng Cao; Rongrong He; Na Han; Zhihui Liu; Lijing Miao; Jun Yin
Journal:  Oxid Med Cell Longev       Date:  2012-07-04       Impact factor: 6.543

7.  Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A.

Authors:  Fei Sa; Bao Jian Guo; Sai Li; Zai Jun Zhang; Hok Man Chan; Ying Zheng; Simon Ming Yuen Lee
Journal:  Parkinsons Dis       Date:  2015-05-17

8.  Protective effect of Anwulignan against D-galactose-induced hepatic injury through activating p38 MAPK-Nrf2-HO-1 pathway in mice.

Authors:  Jiaqi Gao; Zepeng Yu; Shu Jing; Weihai Jiang; Cong Liu; Chunyan Yu; Jinghui Sun; Chunmei Wang; Jianguang Chen; He Li
Journal:  Clin Interv Aging       Date:  2018-10-02       Impact factor: 4.458

9.  Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method.

Authors:  Chi-Lin Li; Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.